Anti-reflux Control to Decrease Post Tonsillectomy Pain

PHASE4TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Laryngopharyngeal RefluxThroat Pain
Interventions
DRUG

Omeprazole

The principal investigator will be contacted and will work with the research pharmacist to obtain the omeprazole (20 mg PO daily for patients \>20kg) and placebo. The placebo does not look like the omeprazole, however this will not be an issue because none of the subjects will have knowledge of how the medications look. The medication will be locked in the designated medication cabinet at each office. It will be prepackaged for a 28 day course. The patient will start the treatment 4 weeks prior to tonsillectomy and stop the day before surgery. The medication will be given to the patient once the consent and assent are signed. This will avoid an unnecessary office visit to improve patient compliance.

Trial Locations (1)

48439

Genesys Regional Medical Center, Grand Blanc

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ascension Health

INDUSTRY